BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24938293)

  • 1. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Peksa GD; Schultz K; Fung HC
    J Oncol Pharm Pract; 2015 Dec; 21(6):409-15. PubMed ID: 24938293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients.
    Kozuch JM; Burt C; Afshar K; Aslam S; Yung G; Mariski M; Golts E; Feist A
    Transpl Infect Dis; 2024 Feb; 26(1):e14209. PubMed ID: 38059638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E
    Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.
    Ceberio I; Dai K; Devlin SM; Barker JN; Castro-Malaspina H; Goldberg JD; Giralt S; Adel NG; Perales MA
    Bone Marrow Transplant; 2015 Mar; 50(3):438-43. PubMed ID: 25599164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
    Kubiak DW; Koo S; Hammond SP; Armand P; Baden LR; Antin JH; Marty FM
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1462-5. PubMed ID: 22564264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation.
    Collins J; Shea K; Parsad S; Plach K; Lee P
    J Oncol Pharm Pract; 2020 Jan; 26(1):5-12. PubMed ID: 30854922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.
    Kieu V; Jhangiani K; Dadwal S; Nakamura R; Pon D
    Transpl Infect Dis; 2019 Feb; 21(1):e13007. PubMed ID: 30295407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
    Gu TM; Lewis JS; Le H; Bubalo JS
    J Oncol Pharm Pract; 2022 Sep; 28(6):1357-1362. PubMed ID: 34192963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal.
    Nakashima T; Inamoto Y; Aoki J; Ito A; Tanaka T; Kim SW; Hashimoto H; Fukuda T; Furukawa T
    Int J Hematol; 2022 Feb; 115(2):158-162. PubMed ID: 35088349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S; Adel N; Jurcic J
    J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label trial of the prophylactic administration of voriconazole in patients who undergo allogeneic hematopoietic stem cell transplantation: study protocol.
    Kunitomi A; Hasegawa Y; Hashimoto H; Saito AM; Iida H
    Nagoya J Med Sci; 2018 Nov; 80(4):591-595. PubMed ID: 30587873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.
    Marr KA
    Curr Opin Infect Dis; 2008 Aug; 21(4):409-14. PubMed ID: 18594294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
    Yamashita T; Fujishima N; Miura M; Niioka T; Abumiya M; Shinohara Y; Ubukawa K; Nara M; Fujishima M; Kameoka Y; Tagawa H; Hirokawa M; Takahashi N
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):111-8. PubMed ID: 27217047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation.
    Mahnke CB; Sutton RM; Venkataramanan R; Michaels M; Kurland G; Boyle GJ; Law YM; Miller SA; Pigula FA; Gandhi S; Webber SA
    Pediatr Transplant; 2003 Dec; 7(6):474-8. PubMed ID: 14870897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study.
    Enderby CY; Heckman MG; Thomas CS; Keller CA
    Clin Transplant; 2014 Aug; 28(8):911-5. PubMed ID: 24931421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
    Khaled SK; Palmer JM; Herzog J; Stiller T; Tsai NC; Senitzer D; Liu X; Thomas SH; Shayani S; Weitzel J; Forman SJ; Nakamura R
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):268-276. PubMed ID: 26325438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation.
    Butts AR; Brown VT; McBride LD; BolaƱos-Meade J; Bryk AW
    J Oncol Pharm Pract; 2016 Apr; 22(2):275-83. PubMed ID: 25802301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose adjustment of immunosuppressants during co-administration of posaconazole: a systematic review.
    Fu C; Chen J; Xu Y; Wu D
    Clin Invest Med; 2018 Mar; 41(1):E5-E15. PubMed ID: 29603686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.